Financial reports
10-Q
2007 Q3
Quarterly report
6 Nov 07
10-Q
2007 Q2
Quarterly report
8 Aug 07
10-Q
2007 Q1
Quarterly report
9 May 07
10-K/A
2006 FY
Annual report (amended)
30 Apr 07
ARS
2006 FY
Annual report to shareholders
27 Apr 07
10-K
2006 FY
Annual report
26 Feb 07
10-Q
2006 Q3
Quarterly report
9 Nov 06
10-Q
2006 Q2
Quarterly report
2 Aug 06
10-K/A
2005 FY
Annual report (amended)
21 Jul 06
Current reports
8-K
Aspreva’s Plan of Arrangement with Galenica Completed
8 Jan 08
8-K
Aspreva Receives Investment Canada Approval for Acquisition by Galenica
24 Dec 07
8-K
Entry into a Material Definitive Agreement
20 Dec 07
8-K
Aspreva Receives Final Court Approval for Acquisition by Galenica
19 Dec 07
8-K
Aspreva Obtains Shareholder Approval for Acquisition by Galenica
17 Dec 07
8-K
Other Events
23 Nov 07
8-K/A
Aspreva Pharmaceuticals Announces Results for Third Quarter 2007
5 Nov 07
8-K
Aspreva Pharmaceuticals Announces Results for Third Quarter 2007
1 Nov 07
8-K
Entry into a Material Definitive Agreement
23 Oct 07
8-K
Entry into a Material Definitive Agreement
18 Oct 07
Registration and prospectus
15-12G
Securities registration termination
11 Jan 08
25-NSE
Exchange delisting
3 Jan 08
S-8
Registration of securities for employees
30 Aug 05
424B4
Prospectus supplement with pricing info
4 Mar 05
F-1/A
Registration statement (foreign) (amended)
1 Mar 05
F-1/A
Registration statement (foreign) (amended)
28 Feb 05
8-A12G
Registration of securities
18 Feb 05
F-1/A
Registration statement (foreign) (amended)
15 Feb 05
F-1/A
Registration statement (foreign) (amended)
11 Feb 05
F-1
Registration statement (foreign)
24 Jan 05
Proxies
No filings